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ABSTRACT Across metazoans, innate immunity is vital in defending organisms
against viral infection. In mammals, antiviral innate immunity is orchestrated by in-
terferon signaling, activating the STAT transcription factors downstream of the JAK
kinases to induce expression of antiviral effector genes. In the nematode Caenorhab-
ditis elegans, which lacks the interferon system, the major antiviral response so far
described is RNA interference (RNAi), but whether additional gene expression re-
sponses are employed is not known. Here we show that, despite the absence of
both interferon and JAK, the C. elegans STAT homolog STA-1 orchestrates antiviral
immunity. Intriguingly, mutants lacking STA-1 are less permissive to antiviral infec-
tion. Using gene expression analysis and chromatin immunoprecipitation, we show
that, in contrast to the mammalian pathway, STA-1 acts mostly as a transcriptional
repressor. Thus, STA-1 might act to suppress a constitutive antiviral response in the
absence of infection. Additionally, using a reverse genetic screen, we identify the ki-
nase SID-3 as a new component of the response to infection, which, along with
STA-1, participates in the transcriptional regulatory network of the immune re-
sponse. Our work uncovers novel physiological roles for two factors in viral infection:
a SID protein acting independently of RNAi and a STAT protein acting in C. elegans
antiviral immunity. Together, these results illustrate the complex evolutionary trajec-
tory displayed by innate immune signaling pathways across metazoan organisms.
IMPORTANCE Since innate immunity was discovered, a diversity of pathways has
arisen as powerful ﬁrst-line defense mechanisms to ﬁght viral infection. RNA interfer-
ence, reported mostly in invertebrates and plants, as well as the mammalian inter-
feron response and JAK/STAT pathway are key in RNA virus innate immunity. We
studied infection by the Orsay virus in Caenorhabditis elegans, where RNAi is known
to be a potent antiviral defense. We show that, in addition to its RNAi pathway,
C. elegans utilizes an alternative STAT pathway to control the levels of viral infection.
We identify the transcription factor STA-1 and the kinase SID-3 as two components
of this response. Our study deﬁnes C. elegans as a new example of the diversity of
antiviral strategies.
KEYWORDS Caenorhabditis elegans, Orsay virus, RNA virus, STAT signaling, innate
immunity
RNA viruses, a highly diverse family known to infect organisms of almost allkingdoms of life, also represent an important burden on human health. Indeed,
their highly mutagenic and adaptive nature is an ever-growing challenge for diagnosis
and treatment and the underlying understanding of host-pathogen interaction. The
ﬁrst and critical step in mounting successful antiviral defense is the conserved innate
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immune response; however, its complexity is yet to be fully apprehended. Several
pathways have been reported for various organisms that differ in their presence or
relative importance. To date, the main pathways can be divided in two categories:
protein-based innate immunity and RNA-based innate immunity. Jawed vertebrates
rely mostly on the powerful interferon (IFN) system, whereas most other eukaryotes
take advantage of the RNA interference (RNAi) machinery (1, 2).
In mammals, the initiation of the interferon response in response to RNA viruses
depends on the RNA helicase RIG-I (retinoic acid-inducible gene I product) and its
paralogs. RIG-I senses double-stranded RNA (dsRNA) intermediates that are generated
during the replication of single-stranded RNA (ssRNA) viruses and initiates production
of the type 1 interferon and inﬂammatory cytokines via activation of the transcription
factors interferon regulatory factor IRF3/7 and NF-B (3, 4). Interferons can in turn
activate the JAK/STAT signaling pathway to induce an antiviral state and mediate viral
control. In essence, binding of interferon to the type 1 interferon receptor (IFNAR) leads
to activation of the receptor-associated tyrosine kinases JAK1 and TYK2, and eventually
to the phosphorylation of the STAT transcription factors. Upon dimerization, STAT
transcription factors can undergo translocation to the nucleus where they activate the
expression of antiviral genes and inﬂammatory response genes (5). On the other hand,
antiviral RNAi relies on the processing by the endoribonuclease Dicer of long double-
stranded viral RNA molecules occurring during the viral cycle. These dsRNA molecules
appear particularly during replication of the RNA genome by the virally encoded
RNA-dependent RNA polymerase. After processing by Dicer, the resulting small inter-
fering RNAs (siRNA) are loaded in the RNA-induced silencing complex (RISC) through
the binding of the siRNA to a protein of the Argonaute family. Recognition of the target
viral RNA by the active RISC eventually leads to its degradation (1).
In principle, all the components required for RNAi are still present in higher
vertebrates, but this might simply reﬂect other biological functions such as microRNA
(miRNA)-based gene regulation. It has also been proposed that the IFN-based innate
immunity and antiviral RNAi might be incompatible (6, 7) or that the evolution of Dicer
in mammalian somatic cells renders it inactive for long dsRNA processing (8).
However, some evidence supports potential roles for RNAi-based antiviral immunity
in mammals (9–11). Similarly, the prominence of the RNAi pathway in ﬁghting viruses
in invertebrates may obscure other mechanisms that the innate immune system may
use to combat viruses in these organisms. One such example is the nematode Caeno-
rhabditis elegans, where antiviral immunity has previously been shown to involve a
potent RNAi response (12).
A single virus, the Orsay virus, has been so far described to infect C. elegans in the
wild (12). This small bipartite single-stranded RNA virus is efﬁciently targeted by the
nematode RNAi machinery to prevent its replication. Surprisingly, DRH-1, a conserved
helicase related to RIG-I, is essential for the antiviral RNAi pathway in C. elegans instead
of the classical interferon response triggered by its mammalian counterpart RIG-I in
mammals (Fig. 1A) (13–15). Interestingly, a previous analysis of gene expression
changes upon viral infection revealed evidence for the induction of antiviral response
genes upon viral infection independent of the RNAi pathway (16). However, neither the
upstream signaling pathway linking these gene expression changes to viral infection
nor the extent to which gene expression alterations directly contribute to antiviral
defense are known. We therefore set out to uncover new signaling pathways involved
in sensing and transducing viral infection.
RESULTS
Identiﬁcation of a STAT transcription factor as a modulator of the infection
response. In order to identify key factors regulating the immune state of C. elegans
after infection by Orsay virus (OrV), we set out to identify conserved regulatory motifs
for the genes that participate in the transcriptional response to infection. Previously we
identiﬁed a set of such putative antiviral response genes that were upregulated upon
infection with the Orsay virus in the laboratory reference strain N2 (16). Interestingly,
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some of these genes, also upregulated upon infection of the antiviral RNAi-deﬁcient
rde-1 mutant, were not upregulated in another domesticated strain of C. elegans,
JU1580, which is also hypersensitive to the Orsay virus (13, 16). The JU1580 strain lacks
the RIG-I homolog DRH-1 (Fig. 1A). This suggested that DRH-1 might be required for a
transcriptional response to infection, independently of RNAi. However, as strains
JU1580 and N2 differ at many loci besides drh-1, including some infection response
genes (12, 13), we decided to test this further by performing microarray analysis to
compare infection-induced genes in strain N2, a drh-1 knockout in the N2 strain,
JU1580, and JU1580 carrying a transgene containing the N2 drh-1 locus (JU1580 drh-1
rescue strain). drh-1 mutants infected with Orsay virus showed changes in gene
expression similar to those of infected JU1580 animals (see Fig. S1 in the supplemental
material), in particular, the lack of upregulation of a set of genes induced in wild-type
FIG 1 Identiﬁcation of a STAT transcription factor signature in immune response against the Orsay virus (OrV) in C. elegans. (A) Schematic representation of
known antiviral pathways in C. elegans. (B) MEME motif enrichment in genes regulated upon infection and conservation of the de novo-identiﬁed motif by
Tom-tom. ID, identiﬁer. (C) Schematic representation of conserved domains between the human STAT-1 and C. elegans STATs. The red bars depict the predicted
phosphorylation sites (20). aa, amino acids. (D) Phylogenetic analysis of STAT transcription factors. Nematodes are indicated in blue, and vertebrates are
indicated in red. Trichinella spiralis, Brugia malayi, Caenorhabditis briggsae, Drosophila melanogaster, Homo sapiens, and Strongylocentrotus purpuratus STATs are
shown on the tree. The tree is based on full-length sequences. Alignment was performed with Muscle. Branch support values are from bootstrap using 1,000
iterations. Only values lower than 0.8 are depicted. The bar shows a branch length of 0.7 nucleotide substitutions per position.
STAT Signaling in Virus Infection in C. elegans ®
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animals. Importantly, this shows that there must be gene expression changes that are
induced independently of the level of viral replication, as both JU1580 and drh-1 have
much higher virus titers than strain N2 or the JU1580 drh-1 rescue strain. This indicates
that there may be signaling pathways governing antiviral gene expression in C. elegans
(Fig. S1).
To gain insights into the nature of the signaling events following viral infection, we
extracted the promoters from the set of genes upregulated in strain N2 after OrV
infection (Data Set S1) and searched for associated motifs (E value of 0.1 against a
background model drawn from the nucleotide composition of the input sequences)
using the motif prediction software MEME (17). We then compared these motifs to
known transcription factor DNA binding motifs in the JASPAR core database using
Tom-tom (18, 19). Remarkably, we identiﬁed an enriched motif with similarity to the
one of STAT transcription factors (Fig. 1B), well-known to have a conserved role in
antiviral defense in mammals. There are two STAT homologs, STA-1 and STA-2, in
C. elegans (Fig. 1C). STA-1 has all the classical functional STAT domains: a coiled-coil
domain for protein-protein interaction, a DNA binding domain, an SH2 domain, and a
putative tyrosine phosphorylation motif (20). STA-2 is similar but lacks the coiled-coil
domain as well as the tyrosine phosphorylation motif (21). Consistent with this, a
phylogenetic tree with C. elegans STA-1 and STA-2 and representative STATs from other
organisms suggests that STA-1 is closely related to mammalian STATs but that STA-2 is
more divergent (Fig. 1D). Interestingly, STA-2 has previously been implicated in an
antifungal response (21), whereas STA-1 has been linked to developmental signaling in
C. elegans (22). We therefore speculated that STA-1 and/or STA-2 might have a
previously unappreciated role in antiviral defense.
To evaluate a potential role for STAT signaling in antiviral defense in C. elegans, we
used reverse transcription-quantitative PCR (RT-qPCR) to quantify the viral loads of sta-1
and sta-2 mutants following infection by the Orsay virus. For controls, we used
wild-type N2 animals and rde-1 mutants, which are hypersensitive to infection due to
the lack of the Argonaute protein RDE-1, essential for the initiation of antiviral RNAi
(Fig. 1A) (12, 23). Surprisingly, sta-1 mutants were 100-fold less permissive to infection
than wild-type animals, whereas sta-2 mutants showed wild-type sensitivity (Fig. 2A).
Double mutants lacking both STAT homologs were no more permissive than sta-1
single mutants were. We conclude that STA-1 but not STA-2 acts in regulating antiviral
defense. Consistent with these observations of viral load, induction of a viral response
reporter gene, comprising gfp driven by the promoter of the viral response gene sdz-6
(16), was reduced in sta-1 mutants compared to strain N2 (P  0.0061) and increased
in rde-1 mutants (P  0.0034) (Fig. S2). Next we generated a single-copy, intrachromo-
somal sur-5::gfp::sta-1 transgene, which drives expression of a green ﬂuorescent protein
(GFP)–STA-1 fusion protein in the intestine and other somatic tissues (Fig. 2B). GFP–
STA-1 accumulated on chromatin in the nuclei of intestinal cells (Fig. 2B). Importantly,
the sur-5::gfp::sta-1 transgene restored wild-type sensitivity to the Orsay virus in a strain
lacking endogenous sta-1 (Fig. 2C). Finally, we asked whether STA-1 acts independently
of the antiviral RNAi pathway using epistasis analysis (Fig. 2D). In rde-1 mutants lacking
the antiviral RNAi response (Fig. 1A), the Orsay virus accumulates to much higher levels
than in the wild-type N2 strain. However, sta-1; rde-1 double loss-of-function mutants
show signiﬁcantly reduced viral loads compared to rde-1 single mutants, suggesting
that sta-1 acts in parallel or downstream of rde-1 (Fig. 2D). Together, these results
identify the C. elegans STAT transcription factor STA-1 as acting in addition to the
antiviral RNAi pathway in the immune response to viral infection in C. elegans.
STA-1 is a repressor of infection response genes. In order to test whether the low
permissivity of sta-1 mutants to viral infection reﬂects a role for STA-1 in the regulation
of antiviral response genes, we performed transcriptome sequencing (RNA-seq) analysis
of wild-type strain N2 and sta-1 mutant animals with or without OrV infection (Fig. 3A).
We then selected transcripts altered signiﬁcantly after OrV infection (DESeq q value
[false-discovery rate] of 0.1; Data Set S2). We observed a robust response to infection
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in N2 animals, whereas fewer transcripts were signiﬁcantly altered in sta-1 mutants
upon infection (Fig. 3B). However, sta-1 mutants displayed a constitutive deregulation
of gene expression compared to N2 animals in the absence of OrV infection (Fig. 3B).
Furthermore, genes that changed expression signiﬁcantly upon infection in N2 showed
a strong trend to be constitutively upregulated in sta-1 mutants, while this was not the
case when all genes were considered (Fig. 3C). These data suggest that STA-1 largely
acts as a transcriptional repressor of an antiviral gene expression program. However,
this antiviral gene expression program includes genes that are up- and downregulated
upon infection, either directly or indirectly (Fig. 3B). We therefore propose that the
lower permissivity of sta-1 mutants to viral infection is caused by either a constitutive
deregulation of the antiviral defense gene expression program or control by STA-1 of
OrV essential host genes.
Next we asked whether STA-1, similarly to STATs in mammals, might bind to DNA in
a sequence-speciﬁc manner to regulate infection response genes. We therefore per-
formed chromatin immunoprecipitation-DNA sequencing (ChIP-seq) analysis of GFP::
STA-1 to determine its genomic binding pattern in noninfected animals expressing the
sur-5::gfp::sta-1 transgene but lacking endogenous sta-1. Through GFP::STA-1 ChIP-seq,
we identiﬁed 2,133 STA-1 peaks across the genome. STA-1 was enriched close to
transcription start sites (TSS) of about 20% of all genes, with an enriched binding peak
located ~200 bp upstream of their TSS (Fig. 3D and Data Set S3). These data are in
agreement with STA-1 acting as a speciﬁc DNA-binding transcription factor to regulate
gene expression. To test further the association of STA-1 binding with the infection
FIG 2 STA-1 is a key transcription factor in the immune response upon Orsay virus (OrV) infection. (A, C, and D) Viral loads
in different strains measured by RT-qPCR on the Orsay virus RNA1 genome after 3 days of infection. The wild-type (WT) control
N2 strain, rde-1(ne219) strain, and strains with sta-1(ok587) and sta-2(ok1860) mutations were infected. Values that were
signiﬁcantly different (P  0.01) from the value for the wild-type control strain (unless otherwise indicated) by a two-tailed
Mann-Whitney U test are indicated with an asterisk. Values that were not signiﬁcantly different (ns) are indicated. n  6 for
panels A and C, and n  4 for panel D. (B) Expression of a single-copy transgene coding for a GFP::STA-1 fusion protein under
the control of a sur-5 promoter in adult animals. DIC, differential interference contrast.
STAT Signaling in Virus Infection in C. elegans ®
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FIG 3 STA-1 acts at the promoter of virus response genes and represses their expression. (A) Schematic representation of the RNA-seq
experiment performed with strain N2 and sta-1(ok587) animals. (B) Representation of the number of genes showing differential expression (DE)
(Continued on next page)
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gene expression response, we used the sequences surrounding the STA-1 peaks in
order to search for enriched motifs. Importantly, we recovered an enriched motif that
was nearly identical to the motif predicted from our gene expression analysis (Fig. 1B)
and matching the mammalian IRF and STAT motifs in the JASPAR core database and
the consensus core interferon-sensitive response element (ISRE) TTCNNTTT (Fig. 3E and
F) (24). Intriguingly, we additionally identiﬁed a separate highly enriched motif with
strong similarity to the consensus sequence for GATA-like transcription factors (Fig. S3).
The predicted GATA and STAT motifs were not found at the same set of genes,
suggesting that GATA-like transcription factors may be able to recruit STA-1 to DNA
independently of STA-1 DNA binding, consistent with previous studies of mammalian
cells (25). This may serve to expand the number of sites bound by STA-1 beyond those
containing a core STAT binding element.
We next tested the association between STA-1 DNA binding and gene expression.
STA-1 binding was strongly enriched at genes with increased expression in sta-1
mutant animals (P  1e25 [Fig. 3G]) (Fig. S4) compared to all genes. However, it is
worth noting that STA-1 binding was also enriched at the promoters of the smaller
number of genes downregulated in the mutant (11/46 downregulated genes versus
122/379 upregulated genes). Thus, although STA-1 largely acts as a constitutive repres-
sor of gene expression, it may have a more complex role at the promoters of some
genes. The intersection of STA-1 binding with all N2 infection response genes, including
those not upregulated in sta-1 mutants was not signiﬁcant, which may indicate that
other signaling pathways are involved in gene expression responses to infection or
technical limitations of identifying STA-1 binding sites from ectopically expressed
GFP–STA-1; however, STA-1 binding was strongly enriched at N2 response genes that
were also upregulated in sta-1 mutants, although there were few of these genes
(Fig. 3G).
STA-1 is required for normal life span. The lower permissivity of sta-1 mutants to
infection raises the question of whether there are negative ﬁtness consequences
associated with STA-1 deﬁciency that might act as trade-offs between resistance to
infection and optimal growth. No obvious defects in development or fecundity were
observed in sta-1 mutants, consistent with published data (20). However, we observed
a signiﬁcant decrease in the median life span of sta-1 mutants (Fig. 4). This may be due
to the constitutive activation of pathogen response genes in sta-1 mutants imposing a
cost on animal development and/or physiology as has been shown in other systems,
e.g., insects (26–28).
The SID-3 kinase acts upstream of STA-1 in regulation of the accumulation of
the Orsay virus. Having demonstrated that STA-1 acts as a constitutive repressor of
antiviral response genes, we wondered how STA-1 activity was inhibited in response to
viral infection. In mammals, STAT proteins are regulated by JAK tyrosine kinase phos-
phorylation (Fig. 5A). There is no conserved homolog of the JAK kinases in C. elegans;
however, the canonical tyrosine phosphorylation site on STA-1 is conserved. Thus, other
kinases may regulate STA-1 activity (20). There is also a growing body of evidence of
JAK-independent phosphorylation of STAT transcription factors, including serine phos-
phorylation (29, 30). Additionally, tyrosine and serine/threonine kinases play an essen-
FIG 3 Legend (Continued)
upon infection in strain N2 (N2 inf), infection in sta-1 mutant animals, or infection in sta-1 mutants compared to N2, as measured by RNA-seq.
(C) Gene expression measured by RNA-seq in a sta-1 mutant animals normalized to the N2 control. All genes or a subset of genes that show
upregulation upon infection in N2 animals are depicted. The box shows the interquartile range, and the whiskers extend to the greatest value
1.5 times the interquartile range from the box. The signiﬁcance of the enrichment is represented as the P value of the Wilcoxon unpaired test.
(D) ChIP-sequencing after immunoprecipitation of the GFP::STA-1 transgene. (Top) The ChIP signal is plotted 1 kb upstream and 1 kb downstream
of all genes anchored at TSS as in references 52 and 53. The heatmap was generated using k-means clustering (three clusters, C1 [cluster 1], C2,
and C3]) of all transcription start sites (TSS) using the GFP::STA-1 signal for clustering. (E) Motif identiﬁcation and conservation by Centrimo (54)
for the 1-kb sequence centered around the summits of the peaks in cluster 2 (C2) in panel D. The asterisk indicates that the IRF1 motif identiﬁed
by Tom-tom matches the reverse complement of the motif found. (F) Example of a upregulated sta-1 gene showing binding of STA-1 by ChIP-seq
in two independent biological replicates (rep1 [replicate 1 ] and rep2). The putative STA-1 binding motif is indicated. (G) ChIP peak enrichment
in different sets of genes. The three sets of genes were genome-wide genes (all genes), genes upregulated in sta-1 versus strain N2 (sta-1 up),
and genes differentially expressed upon infection and upregulated in sta-1 (sta-1 up and infection).
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tial role in antibacterial and antifungal defense in C. elegans (31, 32). To identify
potential kinases upstream of STA-1, we performed an RNAi screen, testing genes with
the serine/threonine/tyrosine-protein kinase catalytic domain IPR001245 (33). The C. el-
egans genome encodes 176 proteins with this domain, 116 of which were available as
clones as part of C. elegans genome-wide RNAi libraries (34, 35). Following RNAi by
feeding, we infected animals with the Orsay virus and then quantiﬁed the viral load for
each of the 116 candidates and additional controls (Fig. 5B and C and Data Set S4).
Using a stringent cutoff (|Z-score|  3), we identiﬁed only a single regulator of viral
load, sid-3. RNAi of sid-3 resulted in ~100-fold reduction of viral RNA accumulation
compared to the control (Fig. 5C). We conﬁrmed that sid-3 is required for permissivity
to viral infection by testing two independent deletion mutants of sid-3 (Fig. 6A and B).
SID-3 is a tyrosine kinase, implicated in systemic RNAi, and is presumed to assist in the
import of dsRNA into the cell during experimental RNAi (36). However, this role in RNAi
is not likely to be linked to its role in antiviral defense, because other genes required
for systemic RNAi, such as sid-1, sid-2, and sid-5, do not show a signiﬁcant difference in
antiviral sensitivity from wild-type strain N2 (37) (Fig. 6C).
We therefore wondered whether SID-3 might act in the same pathway as STA-1. We
quantiﬁed gene expression in sid-3 mutants using RNA-seq. Similar to what we ob-
served for sta-1 mutants, genes that changed expression signiﬁcantly upon infection in
strain N2 showed a strong trend to be constitutively upregulated in sid-3mutants, while
this was not the case when all genes were considered (Fig. 6D and Data Set S2).
Furthermore, the genes upregulated in sid-3 mutant animals showed a striking overlap
with the genes upregulated in sta-1 mutant animals (P  1.2e15). Additionally, sid-3
upregulated genes were enriched for antiviral response genes (P  5.55e10) (Fig. 6E
and Fig. S5). Interestingly, among the viral infection response genes that showed
constitutive upregulation in both sta-1 and sid-3 mutants (Data Set S2), three genes
have been previously implicated in the control of adult life span (C32H11.9, dod-21, and
dod-23), of which two are tandem paralogs of human EPXH1, an epoxide hydrolase
gene, suggesting a putative role in detoxiﬁcation. We also noticed the presence of
dct-17, involved in the innate immune response and localized to the membrane raft, an
important compartment for RNA virus replication (38, 39). Moreover, genes upregulated
in sid-3 mutants, including those shared with sta-1, were enriched for STA-1 binding by
ChIP-seq, suggesting that sid-3 acts upstream of sta-1 in the antiviral gene expression
response (Fig. 6F). We conclude that SID-3 and STA-1 act in the same process to
regulate an innate antiviral immunity program.
FIG 4 STA-1 is required for normal life span. (A) Survival plot showing the relationship between the survival
and age of the wild-type N2 and sta-1mutant animals. (B) Descriptive statistics of the life span experimental
data in panel A. The associated log rank test Bonferroni P value is 2.7e6. std. error, standard error; 95%
C.I., 95% conﬁdence interval.
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Finally, we addressed the relationship between SID-3 and the antiviral RNAi pathway
using epistasis analysis. Interestingly, rde-1;sid-3 double loss-of-function mutants
showed the same permissivity to OrV infection as sid-3 mutants (Fig. 6G). This is in
contrast to what we observed in sta-1;rde-1 mutants (Fig. 2D). Additionally, sta-1;sid-3
FIG 5 The tyrosine kinase SID-3 enables efﬁcient viral replication. (A) Activation of the JAK/STAT signaling pathway in RNA virus infection in humans. Upon
recognition of the viral RNA by a sensor like RIG-I, type 1 interferon (alpha/beta interferon) is released in the environment, recognized by the IFN receptor, and
activates the JAK tyrosine kinase to trigger nuclear translocation of activated STAT transcription factors. IFNa/b, alpha/beta interferon; ISG, interferon-stimulated
genes; P, phosphate. (B) Overview of the RNAi screen. (C) RNAi treatment leading to increased resistance to OrV infection. The viral RNA accumulation after RNAi
treatment is represented by the Z-score of the ΔΔCT values (relative to empty vector [eV]). The red broken lines represent the 99% conﬁdence interval of the
control RNAi (eV), calculated as plus or minus 2.7 standard deviations. The red bars represent the median of the biological replicates for the genes tested or
for controls. The plus signs represent outliers. The inset at the top of the graph depicts all tested clones.
STAT Signaling in Virus Infection in C. elegans ®
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FIG 6 SID-3 and STA-1 regulate a common set of genes. (A) Schematic representation of the different sid-3 alleles available. The sid-3 ok973
allele induces a deletion of 1,330 bp and insertion of 12 nucleotides, deleting exons 11 and 12 and part of exon 13, after the tyrosine kinase
(Continued on next page)
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double mutants also showed a very low permissivity to OrV infection (Fig. 6H). One
likely interpretation of these data is that SID-3 acts both upstream of antiviral RNAi and
upstream of a STA-1-dependent antiviral gene expression program to regulate the
response to OrV infection. We propose a model (Fig. 7) whereby in uninfected animals,
SID-3 is required to maintain repression of viral infection response genes by STA-1.
Upon infection, this signaling is curtailed, inducing an antiviral response program.
DISCUSSION
Here, we uncover a hitherto unappreciated role for the C. elegans homolog of the
mammalian STAT family of transcription factors. We demonstrate that the tyrosine
kinase SID-3 and the STAT transcription factor STA-1 are two new key factors in the
antiviral response in C. elegans. Additionally, we uncover a novel potential signaling
pathway linking the kinase SID-3, previously reported only for systemic RNA interfer-
ence, to STAT signaling. Our results have intriguing implications both for innate
immunity in C. elegans and for the evolution of eukaryotic signaling pathways.
Regulation of antiviral gene expression in C. elegans. Previously there has been
some debate over the extent to which gene expression responses to infection in
C. elegans represent speciﬁc pathogen response pathways or more-general responses
to stress. Our ﬁndings that a STAT family transcription factor is responsible for consti-
tutively repressing infection response genes and that this is relieved upon infection
suggest that at least some part of the transcriptional response to infection is speciﬁc.
Moreover, constitutive upregulation of these genes, as demonstrated in mutants
lacking sta-1, leads to low permissivity to viral infection, although further examination
of the functions of these genes will be needed to understand exactly how their
expression is involved in viral infectivity.
How is the constitutive repression of antiviral response genes by sta-1 relieved upon
viral infection? The fact that sid-3 mutants show loss of sta-1 repression suggests that
phosphorylation of STA-1 is required for it to exert its repressive function. Whether the
phosphorylation is directly mediated by a signaling cascade downstream of the kinase
FIG 6 Legend (Continued)
domain. The sid-3 tm342 allele is a null allele, where an early 821-bp-long deletion (exon 1 to exon 3) and insertion of 7 nucleotides lead to
a premature stop codon. chr X, chromosome X. (B and C) Viral load after 3 days of infection, measured by RT-qPCR on the Orsay virus RNA1
genome. *, P  0.01 by two-tailed Mann-Whitney test. n  6 for each strain. (D) RNA-seq analysis showing an enrichment for infection genes
in sid-3(ok973) upregulated genes. (E) Overlap between genes showing differential expression by RNA-seq upon infection or upregulated in
sta-1 or upregulated in sid-3. (F) Overlap between STA-1-bound genes, as shown by ChIP-seq and sid-3 upregulated genes. (G and H) Viral load
in the indicated strains, measured by RT-qPCR on the Orsay virus RNA1 genome after 3 days of infection. The sid-3 allele used is sid-3(ok973).
In panel G, *, P  0.01 by two-tailed Mann-Whitney test and n  6 for each strain. In panel H, *, P  0.05 by two-tailed Mann-Whitney test
and n  3 for each strain except N2 and n  4 for strain N2.
FIG 7 A STA-1 pathway controls the response to viral infection in C. elegans, a model.
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activity of SID-3 or conversely is caused by disruption of the SID-3 complex upon
infection (as would potentially be mimicked by the sid-3 mutation) is still a point of
discussion. Viral infection may also lead to loss of SID-3 activity and concomitant loss
of STA-1 phosphorylation. The differences in gene expression observed between sta-1
mutant animals and infected animals could then be explained by the difference
between the set of transcription factors active in an infected cell compared to the
noninfected sta-1 mutant.
An interesting clue to the potential role of SID-3 in viral infection comes from its
proposed role in endocytosis (36). Nonenveloped viruses require the endosomal path-
way for entry into cells; it is therefore plausible that viral entry into endosomes may
lead to titration of SID-3 away from its role in signaling to STA-1, leading to relief of
repression. Such an early role for sid-3 in infection is consistent with the ability of sid-3
mutation to suppress the sensitivity of RNAi pathway mutants. Indeed, Dave Wang and
colleagues demonstrate in this issue that sid-3 is required for viral entry (40). Thus, we
hypothesize that the dependence of the virus on sid-3 for its entry has been exploited
by C. elegans as a mechanism to regulate antiviral gene expression. Further work will be
required to reﬁne this signaling pathway.
Evolution of STAT signaling. It is remarkable that the STAT family of transcription
factors has a role in antiviral gene regulation in both mammals and C. elegans, despite
the fact that both upstream and downstream genes in the pathway are not conserved
in mammals and C. elegans. Even more remarkably, the mechanism whereby STAT
transcription factors contribute to gene expression regulation are quite distinct in
nematodes from that in mammals, as while STA-1 is constitutively bound to DNA and
acts as a transcriptional repressor in C. elegans, STATs are activated in response to
infection. Despite this, there appear to be intriguing parallels between STA-1 activity
and the mammalian STAT pathway, in particular the association that we uncovered
between STA-1 binding and GATA transcription and the conserved role of STATs in viral
gene expression responses in C. elegans and mammals.
Our results highlight the remarkable plasticity of signaling pathways through evo-
lution, whereby a central module may retain the same function over millions of years
while acquiring distinct regulatory partners. This ability to both retain and diversify
functionality simultaneously is clearly particularly important in the immune system,
where the speciﬁc nature of the threats involved changes rapidly while their general
modes of action may not. It will be intriguing to explore whether STATs in other
metazoans have similarly diversiﬁed while retaining antiviral activity—it is possible that
the C. elegans mode of STAT action that we uncover here is in fact the original
conserved role of STAT transcription factors in viral responses. If so, vestiges of this
function may be retained in mammalian cells, particularly those without expression of
the JAK pathway.
MATERIALS AND METHODS
Nematode culture and strains.We grew C. elegans under standard conditions at 20°C. The wild-type
strain was var. Bristol N2. The food source used was Escherichia coli strain HB101 (Caenorhabditis Genetics
Center, University of Minnesota, Twin Cities, MN, USA). Detailed information about all strains generated
and used in this study can be found in Table S1 in the supplemental material.
Viral ﬁltrate. Stably infected populations of sensitive animals (JU1580) were transferred to 2-liter
liquid cultures with E. coli HB101 food and grown for 7 days. The supernatant of the culture was
harvested on ice and ﬁltered with a 0.22-m ﬁlter. The resulting viral ﬁltrate was aliquoted and stored
at 80°C.
Viral infection. Two wild-type or three mutant larval stage 4 (L4) animals were added to seeded
50-mm plates. Sixteen hours later, 20 l of Orsay virus ﬁltrate was added to the edge of the bacterial
lawn. Animals were collected 3 days after infection. The animals were washed off the plates with M9
buffer. The animal pellets were washed another three times by pelleting the animals either by gravity on
ice or by centrifugation at 800  g for 2 min in a swinging bucket centrifuge, snap-frozen in liquid
nitrogen, and stored at 80°C.
Life span assay. One hundred animals of each strain were selected and transferred to ten 50-mm
nematode growth medium (NGM) plates. Adult animals were transferred every 2 days to fresh plates for
the duration of egg laying. Their survival was measured by movement of the head. Animals showing no
head movement were gently touched twice with a worm pick and observed for 30 s following each
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touch. Animals that did not move were considered dead and removed from the plate. The survival curves
were plotted and analyzed using OASIS (Online Application for the Survival Analysis) (41).
The experiment was reproduced three times with one representative example illustrated.
RT-qPCR. Lysis of the worm pellets was performed with 5 l of worm pellet and 45 l of the lysis
solution from the Power SYBR green Cells-to-CT kit (Ambion). Ten freeze-thaw cycles and 30 min shaking
at room temperature were performed before the lysis incubation step. The reverse transcription-
quantitative PCR (RT-qPCR) was performed according to the manufacturer’s instructions. The qPCR was
run on a Step One Plus real-time PCR system (Applied Biosystems). The analysis was done using the ΔΔCT
method. The threshold cycle (CT) values of four to six biological replicates per experiment were pooled
to generate the average ΔCT for each strain and an associated standard error (SD). The ΔΔCT value was
calculated with ΔCT in strain N2 as the calibrator. The 2ΔΔCT was plotted as the fold change, and the
interval of conﬁdence is represented by error bars as 2ΔΔCT  SD(ΔCT) and 2ΔΔCT  SD(ΔCT). The signiﬁcance
of the differences observed was tested by a two-tailed Mann-Whitney U test at a signiﬁcance level of P
0.01. The experiments were repeated independently at least twice, and one representative example is
shown in the ﬁgures.
DNA constructs. The viral sensor construct and the gfp::sta-1 construct were generated by Gateway
cloning using the MultiSite Gateway three-fragment vector construction kit (Life Technologies). Gateway
entry clones containing each of the following were generated by standard techniques: sur-5 promoter,
sdz-6 promoter, sta-1 coding sequence, eGFP(F64L/S65T) (eGFP stands for enhanced green ﬂuorescent
protein), and tbb-2 3= untranslated region (3=UTR). The single-copy transgene was generated by
transposase-mediated integration (MosSCI), as described previously (42, 43), at insertion site ttTi5605 on
chromosome II. Injection mixes contained 20 ng/l of vector, 20 ng/l of Mos1 transposase (only for
MosSCI), and 5 ng/l of a pharynx marker. Integration of the extrachromosomal array was performed by
ethyl methanesulfonate (EMS) treatment (50 mM EMS for 4 h).
Sensor scoring. Scoring of the GFP was made by eye under a Leica MZ16F ﬂuorescence stereomi-
croscope. Three biological replicates of the infection were analyzed, with at least 110 animals per
replicate scored by eye, as follows: on for strong GFP signal, dim for weak/medium GFP signal, and off
for no GFP.
Imaging. Adult animals were harvested from a plate; they were washed off in M9 buffer. After three
additional washes in M9 buffer, the pelleted animals were ﬁxed in 0.5 ml of precooled methanol at20°C
for 10 min. The pellet was washed three times in Tris-buffered saline containing 0.1% Tween 20 (TBST)
and then incubated for 10 min in a 4=,6=-diamidino-2-phenylindole (DAPI) solution (0.5 mg/ml in TBST).
The pellet of animals was washed three times in TBST. Five microliters of the pelleted animals was
pipetted directly onto a Cel-line diagnostic microscope slide (Thermo Scientiﬁc) and imaged using a Leica
SP8 upright microscope.
Microarray. To obtain a putative set of signaling response genes triggered by viral infection but not
responding to the level of viral RNA, the array was ﬁrst normalized to the expression of cul-6, as we and
others have shown this to be closely linked to viral RNA levels (16, 44). Microarray data were processed
using rma, and annotations were obtained through the Bioconductor pipeline in the R programming
environment. Differentially regulated genes in any condition were identiﬁed by using t test, P 0.01, and
a twofold difference upon infection. Hierarchical clustering on the drh-1 array was carried out on the set
of differentially regulated genes using the hclust function in R and Ward’s method.
Motif analysis. To speciﬁcally identify potential viral response genes, we normalized the array by
cul-6, as this removed variation in the ﬁnal level of infection. Qualitatively, this identiﬁed trends similar
to those previously published (16), such as putative antibacterial response genes upregulated speciﬁcally
in strain JU1580 and drh-1 upon infection. We identiﬁed genes that were 40% induced relative to cul-6
in strain N2 upon infection and used BiomaRt to download the upstream sequences (Data Set S1). These
sequences were used as input for MEME, attempting to ﬁnd 0 or 1 site per gene. We screened these
manually to avoid spurious hits and then compared potential motifs identiﬁed to the JASPAR core
database. To test enrichment of STAT motifs in STA-1 chromatin immunoprecipitation-DNA sequencing
(ChIP-seq) peaks, we used FIMO to search for the STAT-1 core motif within the 500-bp sequences
upstream of genes containing a STA-1 binding site expressed at an increased level (DESeq q  0.1) in
sta-1 mutants relative to strain N2, applying a false-discovery rate cutoff of 0.2. We compared this to a
random set of genes chosen from the transcriptome sequencing (RNA-seq) data (see below).
RNA-seq. Animals were grown on 50-mm NGM plates, infected or not, and harvested as described
in “Viral infection” above. Total RNA was extracted using TRIsure (Bioline, UK). RNA library preparation
was performed with the NEBNext Ultra RNA Library Prep kit for Illumina with total RNA puriﬁed with the
NEBNext poly(A) mRNA magnetic isolation module, according to the manufacturer’s instructions (NEB,
USA).
RNA-seq analysis. RNA-seq data were aligned to the C. elegans transcriptome WS190 using bowtie2.
Counts were obtained from resulting BAM ﬁles using BEDTools (45), and these were used to generate
normalized data tables using DESeq (46) (Data Set S2). Signiﬁcance between intersecting data sets was
calculated by a Fisher’s exact test (Fig. S4 and Fig. S5). A cutoff of mean 25 normalized reads (normalized
according to DESeq’s negative binomial distribution) for at least one condition was used, and signiﬁ-
cantly altered genes were selected (DESeq Benjamini-Hochberg multiple-test correction q  0.1).
ChIP sequencing. Animals were grown on NGM plates seeded with thick E. coli HB101 food and
harvested as a mixed-stage population. Frozen animals were ground to a ﬁne powder, ﬁxed in
phosphate-buffered saline (PBS) containing 1% formaldehyde for 10 min, quenched with 0.125 M
glycine, and then washed three times in PBS with protease inhibitors. The pellet was resuspended in 1 ml
of FA buffer (50 mM HEPES–KOH [pH 7.5], 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate,
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150 mM NaCl with protease inhibitors) per 4 ml of ground worm powder. Extract was sonicated to a size
range of 200 to 1,000 bp using a Diagenode Bioruptor Pico with a setting of 18 pulses, each pulse lasting
30 s followed by a 30-s pause. The extract was spun for 10 min at 16,000  g at 4°C, and the soluble
fraction was ﬂash frozen in liquid nitrogen and stored at 80°C until use. Each ChIP was prepared in
500 l of FA buffer containing 1% Sarkosyl. Fifteen micrograms of an anti-GFP antibody (ab290) was
incubated with 3 mg of extract. In addition, 10% of extract was saved as a reference. After overnight
rotation at 4°C, 40 l of blocked and washed magnetic protein A Dynabeads (Invitrogen) was added, and
the incubation continued for 2 additional hours. The beads were washed at room temperature twice for
5 min in FA buffer, once in FA buffer with 500 mM NaCl for 10 min, once in FA buffer with 1 M NaCl for
5 min, once in TEL buffer (0.25 M LiCl, 1% NP-40, 1% sodium deoxycholate, 1 mM EDTA, 10 mM Tris-HCl
[pH 8.0]) for 10 min, and twice in Tris-EDTA (TE) (pH 8.0) for 5 min. DNA was eluted twice with 57-l
elution buffer (1% SDS in TE with 250 mM NaCl) at 65°C for 15 min each time. Eluted DNA was incubated
with 20 g of RNase for 30 min at 37°C and then with 20 g of proteinase K for 1 h at 55°C. Input DNA
was also diluted in 114-l elution buffer and treated with ChIP samples. Cross-links were reversed
overnight at 65°C. DNA was puriﬁed on PureLink PCR puriﬁcation columns (Invitrogen). The libraries were
prepared using a modiﬁed TruSeq ChIP Library preparation kit protocol (https://ethanomics.ﬁles
.wordpress.com/2012/09/chip_truseq.pdf). Size selection was performed using Agencourt AMPure XP
beads (Beckman Coulter).
ChIP-seq analysis. (i) Alignment to reference genome. ChIP-seq and RNA-seq libraries were
sequenced using Illumina HiSeq. Reads were aligned to the WS220/ce10 assembly of the C. elegans
genome using BWA v. 0.7.7 (47) with default settings (BWA-backtrack algorithm). The SAMtools v. 0.1.19
“view” utility was used to convert the alignments to BAM format. Normalized ChIP-seq coverage tracks
were generated using the R implementation of BEADS algorithm (48, 49).
(ii) Summed ChIP-seq input. We generated summed input BAM ﬁles by combining good-quality
ChIP-seq input experiments from different extracts (eight experiments). The same summed inputs were
used for BEADS normalization and peak calls.
(iii) Peak calls. Initial ChIP-seq peaks were called using MACS v. 2.1.1 (50) with permissive 0.7 q-value
cutoff and fragment size of 150 bp against summed ChIP-seq input. To generate combined peak calls,
we used the modiﬁed irreproducible discovery rate (IDR) procedure (https://www.encodeproject.org/
software/idr/) with an IDR threshold of 0.05 to combine replicates (Data Set S3). The pipeline for
generating IDR peaks is available here: https://github.com/Przemol/biokludge/blob/master/macs2_idr/
macs2_idr.ipy.
(iv) Mean signal distribution plots and heatmaps. The summarized signal proﬁle and heatmap for
GFP::STA-1 were generated using SeqPlots exploratory analyses and plotting software (51).
RNAi screen. RNAi clones from the Ahringer library (34, 35) were isolated on agar plates containing
carbenicillin (50 g/ml). Single colonies were picked in 2 ml LB plus ampicillin (50 g/ml) and grown for
9 h with shaking at 37°C. Bacteria were then seeded onto 50-mm NGM plates containing isopropyl--
D-thiogalactopyranoside (IPTG) (1 mM), carbenicillin (25 g/ml), and amphotericin B (Fungizone) (2.5 g/
ml). Two days after seeding, two larval stage 4 (L4) animals were added and then grown at 20°C. After
16 h, plates were inoculated with 20 l Orsay virus ﬁltrate. Animals were collected after 3 days, and viral
relative genome copy number was measured by reverse transcription-quantitative PCR (RT-qPCR). For
each round of the screen, we used the following internal controls: N2 strain grown on empty vector
(E. coli L4440 strain) as the normalization control, drh-1 mutant fed on GFP RNAi as a positive control for
infection, and N2 strain fed on drh-1 RNAi clone as a positive control for RNA interference (RNAi). The full
list of the RNAi clones and number of replicates used in this study is available in Data Set S4. Each
replicate of the screen was performed with three biological replicates per RNAi clone treatment, and the
screen was repeated at least twice. The plates with accidental fungal contamination and the plates where
the RNAi treatment led to embryonic lethality were removed from the analysis. The resulting exact
numbers of biological replicates are indicated in Data Set S4. Empty vector treatment was included on
each qPCR plate analyzed and used as the calibrator. The ΔΔCT values were transformed into Z-scores,
calculated as follows: Z-scorei  (ΔΔCTi  ΔΔCTempty vector, n  161)/standard deviation(ΔΔCTempty vector),
where  indicates mean and i is the gene. Boxplots of the Z-score for each treatment are represented
in Fig. 5. Individual values used for the analysis are available in Data Set S4.
Data availability. High-throughput sequencing data sets are accessible through the GEO repository.
All Illumina sequencing ﬁles are available from the GEO database (GSE95230 and GSE99586).
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.00924-17.
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